STIM Stock Analysis: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$1.52
0.03 (2.01%)
▲
5d:
+14.29%
30d:
+14.29%
90d:
+10.14%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: STIM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: STIM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $1.52, which is considered extended relative to its 30-day fair value range of $1.26 to $1.45.
Technical Outlook: Technically, STIM is in a downtrend. Immediate support is located at $1.21, while resistance sits at $1.65.
Market Sentiment: STIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+185.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STIM is in a downtrend. Immediate support is located at $1.21, while resistance sits at $1.65.
Market Sentiment: STIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+185.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.26 -
$1.45
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 185.1% below Wall St target ($4.33)
Fair Price Analysis
30-Day Fair Range
$1.26 -
$1.45
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.65
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.75
Wall Street Target
$4.33
(+185.1%)
Revenue Growth (YoY)
85.7%
Profit Margin
-26.2%
Share & Embed Analysis
Last updated: April 02, 2026 8:24 PM ET
Data refreshes hourly during market hours. Next update: 9:24 PM
Data refreshes hourly during market hours. Next update: 9:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorey Chernett
BUY
531000 shares
2026-03-17
Keith J Sullivan
SELL
8452 shares
2026-02-26
William Andrew Macan
SELL
3427 shares
2026-02-26
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
